Brief: Quince Therapeutics Compensation Committee Determines Executive Officers Would Receive No Salary Increase For 2024
29/01/2024 21:55
Jan 29 (Reuters) - Quince Therapeutics Inc QNCX.O :
* QUINCE THERAPEUTICS: COMPENSATION COMMITTEE DETERMINED
THAT
EXECUTIVE OFFICERS WOULD RECEIVE NO SALARY INCREASE FOR 2024
Source text for Eikon: ID:n0001193125-24-018071
Further company coverage: QNCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges